Astellas Pharma Global Development, Inc., a pharmaceutical company with headquarters in Tokyo, Japan, and Northbrook, Illinois, has promoted Andrew Krivoshik to vice president of medical science-oncology.
Krivoshik received his undergraduate degree in electrical engineering from Princeton in 1990, followed by a medical degree from the University of Illinois College of Medicine at Urbana-Champaign. His clinical internship and residency were at the Mayo Clinic, and his fellowship training was at Duke University. Krivoshik is licensed as both a physician and engineer. More details can be found here.